Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowIndianapolis-based Eli Lilly and Co. has settled a lawsuit brought by the state of Alaska for $15 million, the parties said in a joint announcement early this morning.
Lilly admitted to no wrongdoing as to whether it provided enough information about side effects of its Zyprexa schizophrenia drug. Those side effects include weight gain, high blood pressure and diabetes.
The state contended Lilly should pay costs for the side effects.
Lilly also agreed that Alaska will be treated like other states that might settle future claims with Lilly.
Attorneys for Alaska said the settlement was good for the state, and Lilly officials said the settlement was in the company’s best interest.
Please enable JavaScript to view this content.